Nehal Chopra’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Nehal Chopra’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-32,077	Closed	-$803K	–	29
2017 Q4	$803K	Hold	32,077	–	–	1.21%	12
2017 Q3	$776K	Sell	32,077 -7,323	-19%	-$172K	0.47%	17
2017 Q2	$797K	Hold	39,400	–	–	0.33%	25
2017 Q1	$1.06M	Buy	+39,400	New	+$804K	0.51%	27

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Nehal Chopra's FLXN Position: Q1 2018 in Review

Nehal Chopra sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2018, closing a stake of 32,077 shares — an estimated $803K sold.

Nehal Chopra first reported a position in FLXN in Q1 2017 and held it in 4 quarters. The position peaked at $1.06M in Q1 2017. 134 funds tracked by Wall St. Rank hold FLXN as of Q1 2018.

Nehal Chopra reported no remaining Flexion Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Nehal Chopra sold 32,077 Flexion Therapeutics, Inc. shares in Q1 2018, an estimated $803K.
Nehal Chopra first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
Nehal Chopra's Flexion Therapeutics, Inc. position peaked at $1.06M in Q1 2017.
134 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2018.

Based on Ratan Capital Management's 13F filing for Q1 2018, filed 15 May 2018.